PULSAR HELIUM PROVIDES UPDATE ON TRANSACTION WITH OSCILLATE PLC, WARRANT EXERCISE AND TVR
Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF), a primary helium company, provides an update following its announcements on November 4, 2025, December 19, 2025, January 21, 2026, and February 10, 2026, regarding its option to acquire up to 100% of the shares of Quantum Hydrogen Inc. (“Quantum”), a 100% owned subsidiary of Oscillate PLC (“Oscillate”), in an all-share transaction (the “Transaction”).
On December 18, 2025, the Company issued a total of 292,560 common shares (the “Consideration Shares”) to Oscillate, satisfying the first and second monthly share option tranches valued at US$80,000 each, at a VWAP of C$0.7797 for tranche one and C$0.7543 for tranche two.
On January 20, 2026, the Company issued an additional 145,434 Consideration Shares to Oscillate, satisfying the third monthly share option tranche of US$80,000 at a VWAP of C$0.7556.
On February 9, 2026, the Company issued an additional 80,947 Consideration Shares to Oscillate, satisfying the fourth monthly share option tranche of US$80,000 at a VWAP of C$1.3508.
On March 6, 2026, the Company issued an additional 66,022 Consideration Shares to Oscillate, satisfying the fifth and final monthly share option tranche of US$80,000 at a VWAP of C$1.6581.
Under the terms of the agreement with Oscillate, the Company has now acquired 80% of the shares of Quantum upon having issued to Oscillate all of the required monthly tranches of Consideration Shares. The Company also has the option until May 3, 2027, to acquire the remaining 20% of the shares of Quantum from Oscillate in exchange for US$400,000 of Consideration Shares to be issued in 5 instalments of US$80,000 of Consideration Shares each after the Company has provided notice to Oscillate that it wishes to exercise such option. The Company will evaluate this option in coming months, and prior to the May 3, 2027, deadline date.
The Consideration Shares issued in connection with the Transaction are subject to a four-month-and-one-day hold period from the date of issuance.
Warrant Exercise
In addition, the Company notes that on March 6, 2026, 500,000 share purchase warrants (“Warrant Exercise Shares”) – issued as part of its offering that closed on October 14, 2024 – were exercised at a price of £0.25 per share, generating cash proceeds for the Company of £125,000.
Admission to AIM and Total Voting Rights
Application is being made to the London Stock Exchange plc for the admission of the 500,000 Warrant Exercise Shares to be admitted to trading on AIM, which is expected to occur and dealings commence at 8:00 a.m. on or around March 10, 2026 (“First Admission”). Application is also being made to the London Stock Exchange plc for the admission of the 66,022 Consideration Shares to be admitted to trading on AIM, which is expected to occur, and dealings commence at 8:00 a.m. on or around March 12, 2026 (“Second Admission”).
The new common shares will rank pari passu with the Company’s existing common shares.
On First Admission, the total number of common shares in issue will be 180,642,697 with voting rights. On Second Admission, the total number of common shares in issue will be 180,708,719 with voting rights. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company’s issued share capital pursuant to the Company’s Articles.
On behalf of Pulsar Helium Inc.
“Thomas Abraham-James”
President, CEO and Director
Further Information:
Pulsar Helium Inc.
connect@pulsarhelium.com
+ 1 (218) 203-5301 (USA/Canada)
+44 (0) 2033 55 9889 (United Kingdom)
https://ca.linkedin.com/company/pulsar-helium-inc.
